Last week, $Aethlon Medical Inc(AEMD.US)$ announced that Aethlon Hemopurifier gave positive results in the treatment of two patients who were in critical condition with COVID-19; none of the patients was expected to survive.
Therefore, the blood purifier was used by the FDA's Emergency Use Authorization (EUA). In other words, doctors were forced to utilize a medication that had not yet been completely approved by the FDA because they had no other choice.
At the time of publication, Aethlon Medical stock skyrockets over 300% on heavy vol.
Comment(3)
Wow! What great news.
Hopefully a Covid Cure
Good
Reason For Report